Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer
- 31 July 2007
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 106 (1), 112-118
- https://doi.org/10.1016/j.ygyno.2007.03.007
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitmentBlood, 2005
- Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trialAmerican Journal of Obstetrics and Gynecology, 2005
- Ovarian cancer: Can we make the clinical diagnosis earlier?Cancer, 2005
- Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-Based Radiotherapy of Prostate CancerCancer Research, 2005
- Screening for Familial Ovarian Cancer: Failure of Current Protocols to Detect Ovarian Cancer at an Early Stage According to the International Federation of Gynecology and Obstetrics SystemJournal of Clinical Oncology, 2005
- Screening for Familial Ovarian Cancer: The Need for Well-Designed Prospective StudiesJournal of Clinical Oncology, 2005
- Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinomaGynecologic Oncology, 2004
- The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogensNature Immunology, 2003
- Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal MarkersJournal of the American Statistical Association, 2001
- The performance of screening tests for ovarian cancer: results of a systematic reviewBJOG: An International Journal of Obstetrics and Gynaecology, 1998